Click SIGN UP to receive more information on any of these studies:
Pneumococcal Vaccine Study for Healthy Adults Ages 18-64
• 6 month study with 2-3 office visits
Type 2 Diabetes study for Adults on Long-Acting Insulin
• 9 month study with 22 office visits
Long-Acting Biosimilar Insulin Study for Type 1 Diabetes
• Up to 1 year study with up to 13 office visits
Fatty Liver
• 9 month study with 10 office visits
Low Testosterone with High Cardiovascular Risk
• Up to 5 year study
Diabetes and Kidney Disease
• Multi-year study with 4 visits per year after first year for people with decreased kidney function
Vaccine for Clostridium difficile for people at high risk of hospitalization
• Multi-year study for people ages 60+ that have recently been hospitalized, OR have >10 healthcare visits in 1 year, OR have received antibiotics in last 3 months
